Trial intelligence / Profile preview

Cerebrospinal fluid concentrations of etoricoxib and ketoprofen and their effects on prostaglandin E2 after hip arthroplasty

2008-004484-18Phase 4Completed

Sponsor
Hannu Kokki
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of etoricoxib and ketoprofen in hip osteoarthritis, sponsored by Hannu Kokki. Primary endpoints: Cerebrospinal fluid concentration of etoricoxib, Cerebrospinal fluid concentration of ketoprofen and 1 more. Started Jul 2008; status: completed.

02

Drugs

etoricoxibketoprofen
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on 2008-004484-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004484-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call